These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12691296)

  • 1. Kawasaki disease complicated by cerebral infarction.
    Suda K; Matsumura M; Ohta S
    Cardiol Young; 2003 Feb; 13(1):103-5. PubMed ID: 12691296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy in Kawasaki disease: a report of four cases.
    Harada M; Akimoto K; Otaka M; Sato K; Oda H; Otsuki M; Takahashi K; Kishiro M; Shimizu T
    Pediatr Int; 2013 Oct; 55(5):e111-5. PubMed ID: 24134762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease.
    Tsubata S; Ichida F; Hamamichi Y; Miyazaki A; Hashimoto I; Okada T
    Pediatr Cardiol; 1995; 16(4):186-9. PubMed ID: 7567665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Giant coronary thrombus as a complication of Kawasaki disease].
    Kádár K; Piskóthy A; Bendig L
    Orv Hetil; 1993 Oct; 134(44):2431-3. PubMed ID: 8233462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete Kawasaki disease with coronary artery aneurysm and coronary sinus thrombus.
    Song G; Ren W; Liu Z; Wu D
    Pediatr Cardiol; 2015 Jun; 36(5):1097-9. PubMed ID: 25762471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease.
    Etheridge SP; Tani LY; Minich LL; Revenaugh JR
    Cathet Cardiovasc Diagn; 1998 Nov; 45(3):264-8. PubMed ID: 9829884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose i.v. urokinase for coronary thrombosis in Kawasaki disease.
    Serizawa H; Lin L; Sato T; Takahashi-Igari M; Kato Y
    Pediatr Int; 2019 Mar; 61(3):302-303. PubMed ID: 30854729
    [No Abstract]   [Full Text] [Related]  

  • 8. Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction.
    Kato H; Inoue O; Ichinose E; Akagi T; Sato N
    Acta Paediatr Jpn; 1991 Feb; 33(1):27-35. PubMed ID: 1853711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple coronary artery aneurysms in an adult associated with extensive thrombus formation resulting in acute myocardial infarction: successful treatment with intracoronary urokinase, intravenous heparin, and oral anticoagulation.
    Myler RK; Schechtmann NS; Rosenblum J; Collinsworth KA; Bashour TT; Ward K; Murphy MC; Stertzer SH
    Cathet Cardiovasc Diagn; 1991 Sep; 24(1):51-4. PubMed ID: 1913793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease.
    Harada M; Akimoto K; Ogawa S; Kato H; Nakamura Y; Hamaoka K; Saji T; Shimizu T; Kato T
    Pediatr Int; 2013 Dec; 55(6):690-5. PubMed ID: 23919576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Myocardial Infarction in an Infant With Kawasaki Disease.
    Jone PN; Tapia D; Davidson J; Fagan TE; Browne L; Ing RJ; Kay J
    Semin Cardiothorac Vasc Anesth; 2015 Sep; 19(3):255-9. PubMed ID: 25700695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful emergent coronary thrombolysis in a neonate with Kawasaki's disease.
    Karia VR; Hescock GC; Gedalia A; Ross-Ascuitto N
    Pediatr Cardiol; 2010 Nov; 31(8):1239-42. PubMed ID: 20799030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracoronary tissue-type plasminogen activator treatment in kawasaki disease and acute myocardial infarction.
    Nakagawa M; Watanabe N; Okuno M; Okamoto N; Fujino H
    Cardiology; 2000; 94(1):52-7. PubMed ID: 11111145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of coronary-pulmonary artery fistula with coronary artery aneurysm detected for Kawasaki disease remote phase.
    Inoue T; Miyake T; Mushiake S
    J Clin Ultrasound; 2019 Oct; 47(8):508-510. PubMed ID: 31032930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease.
    Horigome H; Sekijima T; Miyamoto T
    Heart; 1997 Nov; 78(5):517-8. PubMed ID: 9415017
    [No Abstract]   [Full Text] [Related]  

  • 16. Extensive coronary and systemic arterial aneurysm development in severe refractory Kawasaki disease.
    Johnston N; Coleman D; McMahon CJ
    Cardiol Young; 2017 Mar; 27(2):375-376. PubMed ID: 27829480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful revascularization by pulse infusion thrombolysis in a patient with Kawasaki disease combined with acute myocardial infarction.
    Inaba S; Higaki T; Nagashima M; Nishimura K; Ogimoto A; Higaki J; Okayama H
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1091-2. PubMed ID: 20965471
    [No Abstract]   [Full Text] [Related]  

  • 18. Kawasaki syndrome: cerebral and cardiovascular complications.
    Templeton PA; Dunne MG
    J Clin Ultrasound; 1987 Sep; 15(7):483-5. PubMed ID: 3134452
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient Q-waves in an infant with asymptomatic myocardial infarction due to Kawasaki disease.
    Akagawa D; Motoki N; Hachiya A; Akazawa Y
    Cardiol Young; 2019 Feb; 29(2):231-234. PubMed ID: 30520707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful intravenous streptokinase treatment of a child with Kawasaki disease complicated by acute myocardial infarction.
    Liang CD; Huang SC; Su WJ; Chen HY; Lee CH
    Cathet Cardiovasc Diagn; 1995 Jun; 35(2):139-45. PubMed ID: 7656308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.